Migraine Treatment Device Wins Marketing Clearance

Devicemaker eNeura received 510(k) clearance from the FDA for the eNeura Spring TMS for treatment of migraine headache.

The prescription-only device uses single-pulse transcranial magnetic stimulation to induce a mild electric current that modulates nerve cells in the brain. Patients push a button to deliver a magnetic pulse to treat a migraine attack and or to prevent the onset of future migraine attacks.

SpringTMS has CE Marking in Europe for the acute treatment of migraine and migraine prevention.